Literature DB >> 10508944

Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties.

J Soga1, Y Yakuwa.   

Abstract

This study was undertaken to provide investigators working in this particular research field with extensive and useful basic information based on an analysis of a large reliable series of cases regarding tracheal and bronchopulmonary carcinoids and their atypical varieties. A statistical evaluation was carried out which included a total of 1,875 patients with tracheal and bronchopulmonary carcinoids; these were divided into two series, one of 1,595 patients with typical carcinoids and the other of 280 with atypical varieties. These two series were compared regarding various aspects, which included the male to female ratio, age distribution, clinical manifestations, successful preoperative diagnosis, diagnostic accuracy of representative procedures, sites of involvement, tumor size distribution, metastases, carcinoid syndrome, serotonin activity in patients with or without the syndrome, immunohistochemistry, electron microscopy, and postoperative prognosis of the patients. The comparative analyses between the two series disclosed statistically significant differences (p<0.01) regarding various viewpoints; among others, such a difference was proved in the average age, sites of involvement in the lung (central or peripheral), rates and sites of metastases, adrenocorticotrophic hormone (ACTH) production, the association rate of the carcinoid syndrome, and postoperative 5-year and 10-year survival rates (93.3% and 82.1% for the typical carcinoid series versus 68.8% and 58.6% for the atypical variety series: p<0.0001). The postoperative 5-year and 10-year survival rates in the other two groups of patients with or without metastases were likewise calculated and showed a statistically significant difference (72.8% and 52.8% for the former versus 98.3% and 95.4% for the latter: p<0.0001).

Entities:  

Mesh:

Year:  1999        PMID: 10508944

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  21 in total

1.  Intraluminal Bronchial Carcinoid Resection by Bronchoscopy.

Authors:  S P Rai; A P Patil; V Vardhan; R Kumar; P Bhattacharya; M Pethe
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

Authors:  Michael Michael; Rocio Garcia-Carbonero; Matthias M Weber; Catherine Lombard-Bohas; Christos Toumpanakis; Rodney J Hicks
Journal:  Oncologist       Date:  2017-02-20

3.  Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.

Authors:  Martijn van Essen; Eric P Krenning; Willem H Bakker; Wouter W de Herder; Maarten O van Aken; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-27       Impact factor: 9.236

Review 4.  Multidisciplinary management of advanced lung neuroendocrine tumors.

Authors:  Pier Luigi Filosso; Piero Ferolla; Francesco Guerrera; Enrico Ruffini; William D Travis; Giulio Rossi; Paolo Olivo Lausi; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 5.  Multimodal management of neuroendocrine liver metastases.

Authors:  Andrea Frilling; Georgios C Sotiropoulos; Jun Li; Oskar Kornasiewicz; Ursula Plöckinger
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

Review 6.  Management of pulmonary neuroendocrine tumors.

Authors:  Robert A Ramirez; Aman Chauhan; Juan Gimenez; Katharine E H Thomas; Ioni Kokodis; Brianne A Voros
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

7.  Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group.

Authors:  K Kakudo; W Tang; Y Ito; I Mori; Y Nakamura; A Miyauchi
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

8.  Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.

Authors:  Boram Han; Jong-Mu Sun; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

9.  Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study.

Authors:  Astridur Petursdottir; Johanna Sigurdardottir; Bjorn M Fridriksson; Arni Johnsen; Helgi J Isaksson; Hronn Hardardottir; Steinn Jonsson; Tomas Gudbjartsson
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-11-28

10.  A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy.

Authors:  D Kevat; M Chen; D Wyld; N Fagermo; K Lust
Journal:  Obstet Med       Date:  2017-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.